Razor-Edge Insights

• Record-Setting Verdict Upheld: Missouri appeals court stands firm on a $1.5 billion jury award against Monsanto, refusing to budge despite seven aggressive appeal points.
• Glyphosate Litigation Tide Turns: Court rebuffs Monsanto’s reliance on EPA findings and affirms jury’s conclusion that Roundup’s glyphosate-based formula contributed to cancer in multiple plaintiffs.
• Precedent for Punitive Damages: The ruling reinforces constitutional grounds for massive punitive awards when corporations fail to act on credible health warnings.

Monsanto’s Appeal Fails

KANSAS CITY - In a courtroom drama that gripped both the agricultural and legal worlds, the Missouri Court of Appeals for the Western District has affirmed a trial court’s staggering $1.5 billion judgment against Monsanto. The appellate decision, issued under case number WD87059, echoes far beyond the Show-Me State, sending shivers through the corridors of agrochemical companies and their legal teams nationwide.

The consolidated cases involved Daniel Anderson (California), Jimmy and Brenda Draeger (Missouri), and Valorie Gunther (New York)—all with deeply personal accounts of how years of using Monsanto’s flagship herbicide, Roundup, allegedly led to devastating diagnoses of non-Hodgkin’s lymphoma.

• Daniel Anderson, just 32 at diagnosis, told jurors he used Roundup for over a decade across California.
• Jimmy Draegerworked his Missouri land with Roundup, while his wife Brenda filed for loss of consortium, describing how their lives were upended.
• Valorie Gunther’snearly 40-year history with the herbicide in New York culminated in a harrowing cancer battle.

After months of wrangling—including special master recommendations on legal issues and evidence—the trial began in October 2023. The jury, after less than eight hours of deliberation, delivered a verdict that resounded like thunder across corporate America.

Eye-Popping Damages: Jury Sends a Message

The original jury awards included:

• Daniel Anderson:$38 million (compensatory), $500 million (punitive)
• Jimmy Draeger:$5.6 million (compensatory), $500 million (punitive)
• Valorie Gunther:$17.5 million (compensatory), $500 million (punitive)
• Brenda Draeger:$100,000 (loss of consortium)

Monsanto, now owned by Bayer, immediately sought to overturn or reduce the verdicts, filing a flurry of post-trial motions. The court denied most, but did reduce punitive damages to meet the Supreme Court’s constitutional 9-to-1 ratio. Even after remittitur, the damages remained colossal, signaling the court’s view of Monsanto’s ongoing conduct.

Monsanto’s Arguments Sliced Apart

Monsanto’s appeal pressed seven major points—each one dismantled by the appellate panel.

• Federal Preemption:Monsanto invoked the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), arguing state-law claims for failure to warn and design defect were preempted. The court disagreed, ruling state tort claims can coexist with federal regulatory schemes, especially where state law seeks to protect public health.
• Expert Testimony:The company attacked the admissibility of expert opinions referencing a 2022 Ninth Circuit decision that sharply criticized the EPA’s glyphosate assessment. Monsanto called this “prejudicial,” but the appeals court found no categorical bar to judicial opinions as evidence, holding that such references must simply meet standard relevance and fairness criteria.
• Punitive Damages:The court found the trial judge correctly applied constitutional due process, emphasizing that Monsanto continued marketing glyphosate-based Roundup unchanged—even after repeated warnings, jury verdicts, and mounting scientific concerns. The appellate court agreed the reduced punitive awards met constitutional muster.

The Science and the Stakes

At the heart of the battle lies glyphosate, Roundup’s active ingredient. Monsanto’s defense has always rested on the EPA’s controversial conclusion that glyphosate does not pose a cancer risk to humans. Plaintiffs, however, marshaled an array of scientific studies, expert witnesses, and, notably, pointed to the Ninth Circuit’s findings that the EPA’s review process was flawed.

The appellate opinion underscored that “judicial opinions are not automatically excluded from jury trials and must be evaluated, like any other evidence, for their relevance to the issues at hand.” In doing so, the court broadened the scope for how regulatory and judicial findings may shape future toxic tort trials.

The Lawyers Behind the Case

Representing the plaintiffs:

• Matthew Clement, Joshua Moore (Jefferson City, MO)
• Edward Robertson (Leawood, KS)

Representing Monsanto:

• Samuel Hofmeier, Jennifer Berhorst, Robert Adams, Anthony Martinez, Robert Thompson (Kansas City, MO)
• Barbara Smith (St. Louis, MO)
• Kenneth Marshall (Jefferson City, MO)

Why This Ruling Rocks Corporate America

This is more than just another headline-grabbing verdict. The appellate court’s refusal to disturb the jury’s findings or reduce the financial pain sends a warning shot to all corporations: ignore public health warnings and credible scientific evidence at your peril.

Not only does this reinforce Roundup’s vulnerability in courtrooms across America, it emboldens future plaintiffs and may increase the legal risk faced by companies whose products draw similar health concerns.

What’s Next for Monsanto—and the Millions Who Use Roundup?

Monsanto and its parent company, Bayer, are now facing thousands more lawsuits—each with the potential for massive payouts. The ripple effect from Missouri’s courtrooms may shift settlement strategies, drive up the cost of liability insurance, and ultimately reshape the chemical and agricultural industries’ approach to risk and public communication.

Monsanto, for its part, has signaled further appeals are possible—even to the U.S. Supreme Court.

Stay updated with breaking news and sharp analysis:
🔗 Follow us on X @RealUSAHerald